THE HEALTH RESEARCH FOUNDATION ANNOUNCES ITS 2026 MEDAL OF HONOUR AND DIVERSITY & EQUITY IN RESEARCH AWARD WINNERS
Canada NewsWire
OTTAWA, ON, Nov. 18, 2026
OTTAWA, ON, Nov. 18, 2026 /CNW/ -- The Health Research Foundation (HRF) of Innovative Medicines Canada (IMC) is proud to announce the recipients of its 2026 Medal of Honour and Diversity & Equity in Research Award:
Dr. David Malkin, a leading clinician-scientist, whose discoveries have transformed the understanding and treatment of hereditary cancer, is the 2026 Medal of Honour recipient.
Dr. Mandana Vahabi, a pioneering health equity researcher, is the winner of the 2026 Diversity & Equity in Research Award.
Dr. David Malkin: 2026 Medal of Honour Recipient
Dr. Malkin, a pediatric oncologist and cancer genetics researcher at The Hospital for Sick Children (SickKids), is awarded the HRF Medal of Honour for his significant contributions to hereditary cancer research and precision medicine. Over more than three decades of research, his discoveries have transformed how inherited cancer risk is understood, detected, and managed.
He is internationally recognized for his work on Li-Fraumeni syndrome (LFS), a rare inherited condition that significantly increases the risk of developing cancer. Early in his career, Dr. Malkin helped discover that inherited mutations in the TP53 tumour suppressor gene cause LFS — a landmark finding in the understanding of hereditary cancer.
He went on to develop the world's first clinical test for TP53 mutations in children from families with LFS and pioneered the cancer surveillance strategy known as the Toronto Protocol. Now adopted by hundreds of clinical centres worldwide, the protocol enables earlier detection and has changed care for children and families with LFS.
"Dr. Malkin's landmark research has changed how hereditary cancer is understood and managed, giving children and families better possibilities for earlier detection and health outcomes," said Christine Elliott, Chair of the HRF Board of Directors. "We are proud to recognize his extraordinary contributions with the 2026 Medal of Honour."
Dr. Malkin continues to advance cancer prevention and precision medicine, using liquid biopsy, machine learning, and genomics to improve cancer risk prediction, early detection, and personalized treatment for children and young adults.
"Receiving the HRF Medal of Honour is a tremendous honour," said Dr. Malkin. "This recognition reflects the contributions of the patients, families, and colleagues who have made this work possible, and our shared commitment to finding better ways to predict, detect, and treat cancer."
Dr. Mandana Vahabi: 2026 HRF Diversity & Equity in Research Award Recipient
This year's Diversity & Equity in Research Award recognizes Dr. Mandana Vahabi, a leading health equity researcher whose work has helped advance cervical cancer prevention for communities experiencing social and structural barriers to care.
For more than two decades, Dr. Vahabi has advanced research focused on reducing cancer disparities and improving access to prevention and care for historically underserved populations. Her work combines community-engaged research with culturally responsive, trauma-informed, equity-oriented, and evidence-based approaches, ensuring the needs and experiences of communities are reflected in the development of health interventions.
A defining feature of Dr. Vahabi's research is translating evidence into action. Working with communities and health-system partners, she has developed practical, scalable approaches to cervical cancer prevention, including HPV self-sampling to make screening more accessible.
"Dr. Vahabi's work demonstrates the impact of putting equity at the heart of research," said Christine Elliott, Chair of the HRF Board of Directors. "By working alongside communities, she has helped turn evidence into practical solutions that improve cancer prevention and access to care. We are proud to recognize her outstanding contributions with this year's Diversity & Equity in Research Award."
"I am deeply honoured to receive this award," said Dr. Vahabi. "At the heart of this work is a simple goal: ensuring that everyone has a fair opportunity to benefit from cancer prevention and care. This recognition reinforces the importance of continuing to design solutions for communities too often underserved by our health system."
About Health Research Foundation
The Health Research Foundation (HRF) is a Canadian non-profit organization dedicated to fostering healthcare innovation and improved patient outcomes through applied health systems research. The HRF invests in research that reimagines how care is delivered, accessed, and experienced — focusing on bold, evidence-based solutions that drive system-wide transformation. Through strategic collaboration with leading academics, industry innovators, and partners, the HRF provides the resources and networks needed to accelerate meaningful, lasting change.
About Innovative Medicines Canada
Innovative Medicines Canada (IMC) is the voice of Canada's innovative pharmaceutical industry, representing over 40 member companies. It advocates for policies that enable the discovery, development, and delivery of innovative medicines and vaccines to improve the lives of all Canadians. IMC's members contribute $25 billion to the economy, support nearly 150,000 high-value jobs, and invest $3.5 billion in research and development. Guided by the Code of Ethical Practices, all IMC members work with governments, private payers, healthcare professionals, and stakeholders in a highly ethical manner.
SOURCE Health Research Foundation

